The beginning of the era of precision medicine for gastric cancer with fibroblast growth factor receptor 2 aberration Akira OokiKensei Yamaguchi Review Article 16 August 2021 Pages: 1169 - 1183
Clinical biomarkers in adjuvant chemotherapy for gastric cancer after D2 dissection by a pooled analysis of individual patient data from large randomized controlled trials Akira TsuburayaJia GuanShiro Tanaka Review Article 07 August 2021 Pages: 1184 - 1193
Performance evaluation of four prediction models for risk stratification in gastric cancer screening among a high-risk population in China Yue HuHaibiao BaoBin Lu Original Article 21 June 2021 Pages: 1194 - 1202
Prognostic value of patient-reported quality of life for survival in oesophagogastric cancer: analysis from the population-based POCOP study J. J. van KleefW. P. M. DijksterhuisOn behalf of the Dutch Upper GI Cancer Group (DUCG) Original Article Open access 12 July 2021 Pages: 1203 - 1212
Sex-specific prognostic effect of CD66b-positive tumor-infiltrating neutrophils (TANs) in gastric and esophageal adenocarcinoma Alexander QuaasAylin PamukHakan Alakus Original Article Open access 19 May 2021 Pages: 1213 - 1226
A novel genomic classification system of gastric cancer via integrating multidimensional genomic characteristics Haiyong WangYongfeng DingLisong Teng Original Article Open access 06 June 2021 Pages: 1227 - 1241
Propionibacterium acnes overabundance in gastric cancer promote M2 polarization of macrophages via a TLR4/PI3K/Akt signaling Qing LiWei WuHonggang Yu Original Article 02 June 2021 Pages: 1242 - 1253
FHOD1 and FMNL1 formin proteins in intestinal gastric cancer: correlation with tumor-infiltrating T lymphocytes and molecular subtypes Naziha MansuriVanina D. HeuserLaura Lehtinen Original Article Open access 11 June 2021 Pages: 1254 - 1263
Establishment of oxaliplatin-resistant gastric cancer organoids: importance of myoferlin in the acquisition of oxaliplatin resistance Kenji HaradaNaoya SakamotoWataru Yasui Original Article 16 July 2021 Pages: 1264 - 1277
The expression of the alpha1 subunit of Na+/K+-ATPase is related to tumor development and clinical outcomes in gastric cancer Kei NakamuraAtsushi ShiozakiEigo Otsuji Original Article 12 July 2021 Pages: 1278 - 1292
Synergism of rMV-Hu191 with cisplatin to treat gastric cancer by acid sphingomyelinase-mediated apoptosis requiring integrity of lipid raft microdomains Yao LvChu-di ZhangZheng-yan Zhao Original Article Open access 12 July 2021 Pages: 1293 - 1306
Characteristic endoscopic findings of gastric adenocarcinoma of fundic-gland mucosa type Kentaro ImamuraKenshi YaoAkinori Iwashita Original Article 09 July 2021 Pages: 1307 - 1319
A post-marketing observational study of ramucirumab in patients with gastric cancer in Japan Yucherng ChenTaeko KatayoseHiroya Asou Original Article Open access 28 May 2021 Pages: 1320 - 1329
Health-related quality of life in advanced gastric/gastroesophageal junction cancer with second-line pembrolizumab in KEYNOTE-061 Eric Van CutsemMayur AmonkarKohei Shitara Original Article Open access 07 August 2021 Pages: 1330 - 1340
Correction to: Health-related quality of life in advanced gastric/gastroesophageal junction cancer with second-line pembrolizumab in KEYNOTE-061 Eric Van CutsemMayur AmonkarKohei Shitara Correction 18 September 2021 Pages: 1341 - 1341
Tumor mutation burden is correlated with response and prognosis in microsatellite-stable (MSS) gastric cancer patients undergoing neoadjuvant chemotherapy Ziyu LiYongning JiaJiafu Ji Original Article 18 August 2021 Pages: 1342 - 1354
Assessment of indocyanine green tracer-guided lymphadenectomy in laparoscopic gastrectomy after neoadjuvant chemotherapy for locally advanced gastric cancer: results from a multicenter analysis based on propensity matching Ze-Ning HuangSu-YanChang-Ming Huang Original Article 13 August 2021 Pages: 1355 - 1364
Complete one-to-one correspondence between magnifying endoscopic and histopathologic images: the KOTO method II Atsushi MajimaMitsuo KishimotoEiichi Konishi Technical Note 11 August 2021 Pages: 1365 - 1369
Comment on: “Association between triglyceride-glucose index and gastric carcinogenesis: a health checkup cohort study. Gastric cancer, 2021 Aug 5” by Kim et al. Junjie JiangLisong Teng Letter to the Editor 23 August 2021 Pages: 1370 - 1371
Reply to the letter by Junjie Jiang et al. regarding our manuscript “Association between triglyceride-glucose index and gastric carcinogenesis: a health checkup cohort study” Young Min KimJie-Hyun KimJong Suk Park Letter to the Editor 04 September 2021 Pages: 1372 - 1373
Letter to the editor: new response evaluation criteria using early morphological change in imatinib treatment for patients with gastrointestinal stromal tumor Junjie JiangLisong Teng Letter to the Editor 05 September 2021 Pages: 1374 - 1375
Comment on: “Phase II study of S-1 and oxaliplatin as neoadjuvant chemotherapy for locally advanced adenocarcinoma of the gastric or esophagogastric junction: KSCC1601. Gastric cancer, 2021 Aug 11” by Iwatsuki et al Yongfeng DingJunjie JiangNong Xu Letter to the Editor 13 September 2021 Pages: 1376 - 1377